Publications - PulmoTension

Retrouvez les publications scientifiques majeures relatives à l’hypertension pulmonaire auxquelles les membres des centres de référence et de compétence PulmoTension ont contribué.

Rechercher une publication :

01/2025
Dépistage et diagnostic de l’hypertension pulmonaire [Screening and diagnosis of pulmonary hypertension] (nouvel onglet)

Boucly A, Pringuez H, Tromeur C

Rev Prat. 2025 Jan;75(1):36-42. French. PMID: 40476427
01/2025
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies (nouvel onglet)

Hoeper MM, Rosenkranz S, Badesch DB, Humbert M, Langleben D, McConnell JW, Hegab S, Rahner C, Richard JF, Ghofrani HA

Respir Med. 2025 Jan;236:107910. doi: 10.1016/j.rmed.2024.107910. Epub 2024 Dec 10. PMID: 39667586.
11/2024
Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research Collaboration (nouvel onglet)

Kovacs G, Humbert M, Avian A, Lewis GD, Ulrich S, Vonk Noordegraaf A, Souza R, Galiè N, Malhotra R, Saxer S, Grünig E, Egenlauf B, Ewert R, Heine A, Tedford RJ, Houston BA, Kasperowicz K, Kurzyna M, Rosenkranz S, Herkenrath S, Barbera JA, Blanco I, Oliveira RKF, Andersen M, Savale L, Systrom D, Maron BA, Tello K, Condliffe R, Mak S, Baratto C, Hsu S, D'Alto M, McCabe C, Herve P, Olschewski H; PEX-NET (Pulmonary Haemodynamics during Exercise Network) ERS Clinical Research Collaboration

Eur Respir J. 2024 Nov 27;64(6):2400698. doi: 10.1183/13993003.00698-2024. PMID: 39603672; PMCID: PMC11684422.
11/2024
MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study (nouvel onglet)

Humbert M, Hassoun PM, Chin KM, Bortman G, Patel MJ, La Rosa C, Fu W, Loureiro MJ, Hoeper MM

Eur Respir J. 2024 Nov 14;64(5):2401110. doi: 10.1183/13993003.01110-2024. PMID: 39255991; PMCID: PMC11561403
11/2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers (nouvel onglet)

Gerges C, Beurnier A, Jaïs X, Hervé P, Lau EMT, Girerd B, Günther S, Bouchachi A, Jevnikar M, Boucly A, Bogaard HJ, Simonneau G, Sitbon O, Savale L, Chemla D, Humbert M, Montani D

Chest. 2024 Nov;166(5):1173-1183. doi: 10.1016/j.chest.2024.06.3808. Epub 2024 Jul 24. PMID: 39059577.
11/2024
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial (nouvel onglet)

Sitbon O, Skride A, Feldman J, Sahay S, Shlobin OA, McLaughlin V, Ghofrani HA, Langleben D, Parsley E, D'Souza G, Marmon T, Kamau-Kelley W, Jones R, Grewal R, Wring S, Palacios M, Naik H, Denning J, Lazarus HM, Humbert M

Lancet Respir Med. 2024 Nov;12(11):865-876. doi: 10.1016/S2213-2600(24)00226-1. Epub 2024 Sep 19. PMID: 39307144.
11/2024
Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH (nouvel onglet)

Escal J, Poenou G, Delavenne X, Bezzeghoud S, Mismetti V, Humbert M, Montani D, Bertoletti L

Blood Rev. 2024 Nov;68:101240. doi: 10.1016/j.blre.2024.101240. Epub 2024 Sep 4. PMID: 39245607.
10/2024
Definition, classification and diagnosis of pulmonary hypertension (nouvel onglet)

Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, Badesch D, Montani D

Eur Respir J. 2024 Oct 31;64(4):2401324. doi: 10.1183/13993003.01324-2024. PMID: 39209475; PMCID: PMC11533989.
10/2024
Effect of sotatercept on circulating proteomics in pulmonary arterial hypertension (nouvel onglet)

Savale L, Tu L, Normand C, Boucly A, Sitbon O, Montani D, Olsson KM, Park DH, Fuge J, Kamp JC, Humbert M, Hoeper MM, Guignabert C

Eur Respir J. 2024 Oct 31;64(4):2401483. doi: 10.1183/13993003.01483-2024. PMID: 39227073; PMCID: PMC11525346
10/2024
Embracing the challenges of neonatal and paediatric pulmonary hypertension (nouvel onglet)

Ivy D, Rosenzweig EB, Abman SH, Beghetti M, Bonnet D, Douwes JM, Manes A, Berger RMF

Eur Respir J. 2024 Oct 31;64(4):2401345. doi: 10.1183/13993003.01345-2024. PMID: 39209483; PMCID: PMC11525338.

Rechercher une publication :

Dépistage et diagnostic de l’hypertension pulmonaire [Screening and diagnosis of pulmonary hypertension] (nouvel onglet)

Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies (nouvel onglet)

Prognostic relevance of exercise pulmonary hypertension: results of the multicentre PEX-NET Clinical Research Collaboration (nouvel onglet)

MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study (nouvel onglet)

Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers (nouvel onglet)

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial (nouvel onglet)

Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH (nouvel onglet)

Definition, classification and diagnosis of pulmonary hypertension (nouvel onglet)

Effect of sotatercept on circulating proteomics in pulmonary arterial hypertension (nouvel onglet)

Embracing the challenges of neonatal and paediatric pulmonary hypertension (nouvel onglet)